Skip to main content
Glama
vikranthviki

Causal Decision Agent

by vikranthviki

did

Read-only

Fit a two-period two-group difference-in-differences model to estimate causal treatment effects from binary treatment and post-period indicators.

Instructions

Fit a classic 2-period 2-group difference-in-differences. Pass treatment / time / post column names. For staggered adoption across many cohorts use callaway_santanna instead. Validation: validated evidence tier (known-truth, reference, external-parity, or Monte Carlo artifact).

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
yYesOutcome column
postNoBinary post-treatment period indicator
timeYesTime column
treatYesBinary treatment-group indicator
detailNoPayload depth: 'minimal' (~150 tokens) for sub-step calls where only the point estimate is needed; 'standard' (~1K tokens) for diagnostics + coefficient table; 'agent' (~2K tokens, default) adds violations / next_steps / suggested_functions so the LLM can plan its next call without another round-trip.agent
as_handleNoIf true, cache the fitted result on the server and return result_id + result_uri alongside the JSON payload so a subsequent tools/call can chain without re-running.
data_pathYesAbsolute path or URL to a data file. Supported: .csv / .tsv / .txt (delimited), .parquet / .pq, .feather / .arrow, .xlsx / .xls, .dta (Stata), .json / .jsonl. Schemes: file://, s3://, gs://, https://.
result_idNoOptional handle to a previously-fitted result (returned by an earlier call when as_handle=true). Tools that operate on a fitted object accept this in place of re-supplying data_path + columns.
data_columnsNoOptional column projection. Parquet/Feather/Stata loaders honour this for fast partial reads.
data_sample_nNoOptional uniform random subsample size (seed=0, deterministic) — useful on huge panels.

Output Schema

TableJSON Schema
NameRequiredDescriptionDefault

No arguments

Schema Changelog

Changes observed during successful MCP inspections.

  1. First observedv0.1.0

TDQS

A4.4/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations declare readOnlyHint=true and openWorldHint=false, so the safety profile is already covered. The description adds the validation evidence tier context ('known-truth, reference, external-parity, or Monte Carlo artifact'), which is useful behavioral context beyond the annotations. It doesn't describe output details, but the output schema exists and the annotations cover the read-only nature.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Three sentences with zero waste. The core purpose is front-loaded, the alternative is named in the second sentence, and the validation context is a compact final sentence. Every sentence earns its place.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a 10-parameter tool with 100% schema coverage, an output schema, and read-only annotations, the description is largely complete. The only minor gap is that it doesn't explain what the returned result contains, but the output schema presumably covers that. The validation tier mention adds useful context for an agent deciding whether to trust the result.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, so the schema already documents all 10 parameters. The description adds the conceptual role of the columns (treatment / time / post) but doesn't add meaning beyond what the schema provides. Baseline 3 is appropriate since the schema does the heavy lifting.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a specific verb ('Fit') and resource ('classic 2-period 2-group difference-in-differences'), and explicitly names the required column roles (treatment / time / post). It also distinguishes itself from callaway_santanna for staggered adoption, which is a clear sibling differentiation.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly says to use callaway_santanna instead for staggered adoption across many cohorts, giving a clear when-not-to-use condition. It also tells the agent to pass treatment / time / post column names, which is direct usage guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Deploy Server

Other Tools